SDI Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

SDI (ASX:SDI) Full Year 2024 Results

Key Financial Results

• Revenue: AU$111.2m (up 3.1% from FY 2023).
• Net income: AU$10.4m (up 48% from FY 2023).
• Profit margin: 9.4% (up from 6.5% in FY 2023).
• EPS: AU$0.088 (up from AU$0.059 in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

SDI EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 4.1%. Earnings per share (EPS) exceeded analyst estimates by 8.3%.

The primary driver behind last 12 months revenue was the Australia segment contributing a total revenue of AU$66.3m (60% of total revenue). The largest operating expense was General & Administrative costs, amounting to AU$47.5m (81% of total expenses). Explore how SDI's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Medical Equipment industry in Australia.

Performance of the Australian Medical Equipment industry.

The company's shares are down 1.1% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 2 warning signs for SDI you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.